Nikkhil K Masurkar, CEO of Mumbai-based Entod Pharmaceuticals, has been appointed Vice Chairperson of the R&D and Innovation Committee of the Indian Drug Manufacturers Association (IDMA) for the 2025–2026 term.
As India’s largest pharmaceutical industry body, IDMA represents over 1,100 member companies, the majority of which are Micro, Small, and Medium Enterprises (MSMEs).
Masurkar's strong leadership qualities, dynamic entrepreneurial spirit and sharp business acumen together with impressive pharmaceutical & research skills have made Entod Pharmaceuticals into one of the fastest growing speciality pharmaceutical & healthcare companies in India and abroad.
The R&D and Innovation Committee of IDMA plays a vital role in shaping R&D policy recommendations, fostering academia-industry linkages, and advocating for regulatory reforms that strengthen India’s position as a global pharmaceutical powerhouse.
Under the leadership of Chairperson Sanjiv Navangul (MD & CEO, Bharat Serums & Vaccines), and alongside an esteemed committee, Masurkar will help mobilise collaborative initiatives that promote research-led development, facilitate strategic engagement with scientific institutions, and accelerate the innovation momentum among MSMEs.
